LAE-32
Jump to navigation
Jump to search
| File:LAE-32.svg | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Other names | LAE, Lysergic acid ethylamide, d-lysergic acid ethylamide, d-ethyllysergamide, |
| Routes of administration | Oral |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| CAS Number | |
| Chemical and physical data | |
| Formula | C18H21N3O |
| Molar mass | 295.378 g/mol |
D-Lysergic Acid Ethylamide, (LAE-32) is a derivative of ergine. It is reported to have some LSD-like effects but is weaker and shorter lasting, with an active dose reported to be between 0.5 and 1.5 milligrams.
Template:Pharmacology-stub Template:Hallucinogenic lysergamides
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Psychedelics
- Lysergamides